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Aenne Glass,d Wolfgang Schareck, MD, PhD,a Hüseyin Ince, MD, PhD,b and
Christoph A. Nienaber, MD, PhD,b Rostock, Germany
Objective: This study analyzed the outcome of a combined endovascular and debranching procedure for hybrid aortic arch
repair (HAR) in patients with complicated type B aortic dissection.
Methods: Between February 2006 and August 2012, HAR was performed in 75 consecutive patients, with retrospective
analysis of a subgroup of 45 patients who underwent HAR with complicated acute (n[ 10), subacute (n[ 7), or chronic
(n [ 28) type B dissection as the underlying disease. Descriptive statistics were computed for continuous and categoric
variables. The interval to death or last follow-up was estimated using the Kaplan-Meier method.
Results: The patients were a mean age of 59.9 6 10.7 years (median, 59.2; range, 35-78 years). Complete supra-aortic
debranching was performed in six (13%) in zone 0 (procedure time, 200 minutes; range, 185-365 minutes) and partial
debranching in 39 (87%), comprising 16 (36%) in zone 1 (procedure time, 120 minutes; range, 75-250 minutes) and
23 (51%) in zone 2 (procedure time, 91 minutes; range, 70-210 minutes). Technical success was achieved in 86.7% (39 of
45). Thirty-day mortality was 4.4% (two of 45), with an in-hospital mortality of 11.1% (ﬁve of 45) as a result of three
additional deaths after days 33, 35, and 111. Comparing HAR for type B dissection after complete debranching in six and
partial debranching in 39, the overall in-hospital mortality was 67% (four of six) and 2.6% (one of 39), respectively. After
a median follow-up of 20.8 months (range, 0.3-70 months), the overall mortality was 13.3% (six of 45), with Kaplan-
Meier survival estimate of 85% at 1 year. Stroke rate was 8.8% (four of 45). Paraplegia developed in one patient
(2.2%), with complete recovery after spinal drainage. Cardiac complications occurred in three patients (6.7%), pulmonary
complications in 10 (22.2%), and renal insufﬁciency requiring dialysis developed in ﬁve (11%). Retrograde dissection
occurred in one patient (2.2%) 14 days after complete debranching and zone 0 thoracic endovascular aortic repair, with
fatal outcome. No bypass dysfunction was seen during follow-up. The overall early and late endoleak rates were 27%
(12 of 44) and 43% (13 of 30), respectively. Eight patients (18%) required reintervention, with freedom of reintervention
in 91% at 1 year and 81% at 2 years.
Conclusions: HAR in zone 1 and 2 appears a viable alternative to conventional aortic arch surgery in patients with
complicated type B dissection. Stroke and endoleaks remain complications that need to be addressed. Treatment of type B
aortic dissection with complete supra-aortic debranching and thoracic endovascular aortic repair in zone 0, however, is
associated with high mortality, which might be reduced by improved technology using branched stent grafts. (J Vasc Surg
2013;58:1490-6.)Endovascular treatment of thoracic aortic pathologies
is a well-accepted alternative for open surgery.1 Type B
aortic dissection may be managed conservatively unless
associated symptoms of complications arise, including
malperfusion or imminent rupture.2 In the presence of
complicated type B aortic dissection, thoracic endovascular
aortic repair (TEVAR) is a therapeutic option considering
the superior outcome compared with open surgical treat-
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0lumen expansion are essentially governed by anatomy and
the patient’s clinical status and comorbidity proﬁle.
Because the aortic arch is involved in >25% (by intimal
tear in the arch or propagation from the descending aorta),
the proximal landing zone may need to be extended for
proper ﬁxation of endografts.3 Combined supra-aortic
debranching techniques and thoracic stent grafting has
shown to be a promising option to avoid open surgery in
such challenging anatomies.4,5 The aim of this retrospec-
tive study was to analyze outcomes with hybrid interven-
tions in complicated type B aortic dissection.METHODS
Patient population. We performed a retrospective
review of our single-center results of all patients who
underwent hybrid arch repair (HAR) for complicated
type B aortic dissection between February 2006 and
August 2012. Inclusion criteria for HAR included any
involvement of the aortic arch in complicated type B
dissection or an inadequate landing zone for TEVAR at
the proximal descending aorta. Surgical repair was only
Table I. Baseline characteristics of 45 patientsa with
aortic arch repair for type B aortic dissection
Variable No. (%) (N ¼ 45)
Male sex 38 (84)
American Society of Anesthesiologists 3 þ 4 40 (89)
Hypertension 39 (87)
Coronary artery disease 13 (29)
Previous myocardial revascularization 9 (20)
Previous stroke 4 (9)
Pulmonary disease 15 (33)
Impaired renal function 14 (31)
Previous operation for type A aortic dissection 4 (9)
Previous TEVAR for type B aortic dissection 6 (13)
Rupture 2 (4)
Malperfusion 16 (36)
TEVAR, Thoracic aortic endovascular repair.
aPatients were a median age of 59 years (range, 35-78 years).
Table II. Indication for hybrid aortic arch repair (HAR)
in 45 patients with type B aortic dissection with
correlation to zone 0, 1, and 2
Indication
Zone 0, Zone 1, Zone 2,
TotalNo. (%) No. (%) No. (%)
Acute 1 (10) 4 (40) 5 (50) 10
Subacute 1 (14) 3 (43) 3 (43) 7
Chronic 4 (14) 9 (32) 15 (54) 28
Table III. Supra-aortic debranching in 45 patients with
type B aortic dissection
Variable No. (%) (N ¼ 45)
Presentation
Emergent 7 (16)
Elective 38 (84)
Zone 0 debranching 6 (13)
Ascending-IA/LCCA bifurcated bypass 6 (100)
Including LCCA-LSA bypass 5 (83)
Zone 1 debranching 16 (36)
RCCA-LCCA bypass retropharyngeal 11 (68)
Including LSA-transposition 7 (64)
Including LCCA-axillary bypass 1 (9)
RCCA-LCCA bypass pretracheal 2 (13)
Including LCCA-LSA bypass 1 (50)
Bypass with LCCA reinsertion
RCCA-LSA 2 (13)
RCCA-axillary 1 (6)
Zone 2 debranching 23 (51)
LSA-transposition 16 (70)
LCCA-LSA bypass 7 (30)
IA, Innominate artery; LCCA, left common carotid artery; LSA, left
subclavian artery; RCCA, right common carotid artery.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 6 Bünger et al 1491considered in a pre-existing ascending aortic aneurysm that
limited proximal anchorage of the stent graft.
All patients agreed to the conditions of the procedure
and the use of their outcome data by signing a consentform. Data were collected for patient demographics,
indications for intervention, risk factors, procedures, and
outcomes.
We used the Ishimaru classiﬁcation to categorize the
proximal landing zone of the stent graft.6 Aortic type B
dissection is categorized by the time from pain onset:
acute #2 weeks, subacute between 2 and 6 weeks, and
chronic >6 weeks.
Debranching procedure. All bypass grafts were per-
formed in an operating theater with the patient under
general anesthesia and with the use of intravenous heparin.
Ascending aortic bifurcated grafts (14-mm or 16-mm
Dacron [DuPont, Wilmington, Del]) were inserted
through a median sternotomy with side-biting the
ascending aorta. Access to supra-aortic vessels was achieved
through vertical or transverse neck incisions for the carotid
arteries and a transverse left supraclavicular incision for the
left subclavian artery (LSA). Carotid-to-carotid 8-mm
expanded polytetraﬂuoroethylene grafts were tunneled in
front of the trachea or behind the pharynx by digital tissue
separation.
Revascularization of the LSA, if indicated, was achieved
by LSA transposition to the carotid artery or carotid-to-
subclavian or carotid-to-axillary bypass. LSA revasculariza-
tion was considered necessary in the presence of a dominant
left vertebral artery, a patent left internal mammary artery
used for coronary bypass (contraindication for subclavian
transposition), or when extensive aortic coverage was
planned (>20 cm length of stent graft). To avoid type II
endoleak after TEVAR, surgical occlusion of the innomi-
nate artery, left carotid artery, or LSA was performed, if
technically achievable.
TEVAR procedure. All TEVAR procedures were per-
formed in a hybrid interventional suite with the patient
under general anesthesia. A standardized TEVAR protocol
was used, with a standby option of spinal ﬂuid drainage.
Brieﬂy, true lumen access was obtained from a transfemoral
approach after an inguinal cutdown. Through a 5F pigtail
catheter, a 300-cm-long stiff wire (Lunderquist, Cook,
Denmark) was advanced in the true lumen to the ascending
aorta. Transesophageal ultrasound imaging was used to
conﬁrm navigation in the true lumen. A 4F pigtail catheter
was placed through the right brachial artery to the aortic
arch for repeated angiographies using 350 mg/mL iodine
contrast (Accupaque 350; GE Healthcare, Waukesha,
Wisc) during the procedure.
All stent grafts were deployed in the desired position
under rapid pacing, as described elsewhere.7 We have
adopted the policy to use rapid pacing during stent graft
deployment in every case, without any problems or side
effects, to avoid any wind-sock effect or misplacement.
The period of pacing never exceeded 12 seconds and was
considered safe.
TEVAR was accomplished as a sequential procedure
with supra-aortic debranching in 14 patients (32%) or in
a staged fashion 2 to 4 days after debranching in 30
(68%), depending on the acuity of presenting symptoms
and comorbidities. The reason for a default staged
Table IV. Technical data after debranching thoracic endovascular aortic repair (TEVAR) in 44 patients with type B aortic
dissection
Variablea Zone 0 Zone 1 Zone 2 Total
Patients 6 (14) 16 (36) 22 (50) 44 (100)
X ray time, minutes 22.7 (9-68) 15.9 (10-36) 13.2 (6-24) 15.2 (6-68)
Contrast load, mL 250 (210-610) 173 (120-300) 190 (90-320) 200 (90-610)
Stent coverage length, cm 150 (150-212) 150 (81-209) 157 (110-224) 150 (81-224)
aCategoric data are shown as number (%) and continuous data as medium (min-max).
Table V. Details of six of 45 patients with fatal outcome after hybrid aortic repair for type B aortic dissectiona
Age,
years Sex Presentation Zone Emerg
TEVAR
complex Reason
X ray time,
minutes
Contrast
load, mL Cause of death
Days
after
TEVAR
57 F SA visceral MP 0 No Yes Steep arch 44 600 Stroke 10
55 M A expansion 0 Yes Yes MI, PCI 35 610 Type A dissection 14
75 M C expansion 1 Yes Yes H/O TEVAR 15 135 MOF 33
78 M C expansion 0 No Yes H/O TEVAR 23 210 MOF 35
77 F C expansion 0 Yes Yes H/O
TEVARb
38 310 MOF 111
77 F A rupture 2 Yes No . 19 220 Unknown 188
A, Acute; C, chronic; Emerg, emergency; F, female; H/O, history of; M, male; MI, myocardial infarction; MOF, multiorgan failure; MP, malperfusion; PCI,
percutaneous coronary intervention; SA, subacute; TEVAR, thoracic endovascular aortic repair.
aOne patient only received zone 2 debranching, without concurrent TEVAR.
bSteep arch required sternotomy and conversion to open stent graft deployment.
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potential perioperative complications, such as stroke or
others, however, at the expense of two anesthesias. With
a separation by maximally 72 hours, the issue of prolonged
waiting is negligible.
Stent graft dimensions were determined by measuring
the diameter of the proximal landing zone in orthogonal
view and using a workstation to reformat the computed
tomography angiogram (CTA). Oversizing by >10% was
avoided. Balloon dilatation was only performed when
a residual endoleak was noticed.
The provisional extension to induce complete attach-
ment (PETTICOAT) concept8 has been used in 10
patients (23%) with sustained true lumen collapse despite
proximal stent grafting.
Follow-up. The follow-up protocol included post-
operative CTA before discharge, a clinical examination,
and a CTA 3 months postoperatively and annually there-
after. Duplex scanning to monitor bypass function was also
performed. Median follow-up was 20.8 months (range,
0.3-69.7 months).
Deﬁnitions and statistical analysis. Outcome criteria
were deﬁned according to the reporting standards for
TEVAR.9 All data were stored and analyzed using SPSS
20.0 software (IBM Corp, Armonk, NY). Descriptive
statistics were computed for continuous and categoric
variables. The statistics computed included mean, median
(minimal-maximal), and standard deviations of continuous
variables and frequencies and percentage frequencies of
categoric factors. The time to death or last follow-up wasestimated and graphically presented using the Kaplan-
Meier method. Differences between curves were assessed
by the Mantel log-rank test for censored survival data.
The Cox proportional hazards model was used to
assess the independence of overall survival from prognostic
factors by estimating hazard ratios and 95% conﬁdence
intervals. First, univariate analyses were performed to reveal
unadjusted associations between prognostic variables and
survival. Thereafter, variables yielding P values # .2 in
the univariate analyses were entered in the multivariate
model to highlight some adjusted associations between
the outcome and covariates that were univariate of border-
line signiﬁcance. All P values resulted from two-sided statis-
tical tests, and P values < .05 were considered to be
statistically signiﬁcant.
RESULTS
Preoperative patient characteristics and indications for
HAR are described in Tables I and II, respectively. Of
the patients in our series treated by HAR, 28 revealed
chronic expanding aortic dissection, of which 10 patients
(36%) were operated on for type A aortic dissection
(4 patients) or treated endovascularly for type B aortic
dissection (6 patients) in the past.
Details of 45 supra-aortic debranching operations are
summarized in Table III. Zone 0 debranching was per-
formed in six patients (13%), with a procedure time of
200 minutes (range, 185-365 minutes). Partial debranch-
ing was performed in 39 patients (87%), including zone 1
in 16 (36%), with a procedure time of 120 minutes (range,
Fig 1. Kaplan-Meier survival analysis is shown for 45 patients with hybrid arch repair (HAR) in zone 0 (six patients;
blue line), zone 1 (16 patients; green line) and zone 2 (23 patients; light green) for type-B aortic dissection. Note that
one patient only received zone 2 debranching, without concurrent thoracic endovascular aortic repair (TEVAR).
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time of 91 minutes (range, 70-210 minutes). In 89% of all
debranching procedures, revascularization was performed
of the LSA (38 patients) or axillary artery (two patients).
In nine patients (20%), surgical occlusion of the proximal
LSA was not performed, comprising ﬁve patients without
LSA revascularization, two with LSA revascularization,
and two with axillary bypass.
Procedural data from TEVAR are summarized in
Table IV. Several commercially available stent graft systems
were used, with a total of 64 stent grafts (37 tapered
devices) implanted in 44 patients, comprising Valiant
(Medtronic, Minneapolis, Minn), 46; Zenith TX2 (Cook,
Bloomington, Ind), 14; and Relay (Bolton Medical,
Sunrise, Fla), four. Four of nine patients without surgical
LSA occlusion received interventional LSA occlusion by
a vascular plug, which was performed routinely since
2010. One patient required chimney stenting for the
innominate artery after a proximally migrating stent graft
caused unintended partial occlusion.
Technical success. Technical success was achieved in
86.7% (39 of 45). Six failures were documented, constitutingfour type IA endoleaks (9%), one stent graft insertion
through an antegrade approach to overcome inappropriate
transfemoral stent graft placement, and one failure to
complete TEVAR after partial debranching due to severe
pneumonia.
Mortality. All of the patients with fatal outcome are
summarized in Table V. Early mortality (#30 days) was
4.4% (two of 45). Both patients underwent uneventful
complete debranching, followed by TEVAR. Stent place-
ment in one patient was difﬁcult due to a gothic arch
resulting in a long procedure; this patient died at day 10
after a major stroke. Another patient sustained a myocardial
infarction, recognized at the beginning of TEVAR. He
received a coronary stent for myocardial revascularization,
followed by successful TEVAR, but died of retrograde type
A dissection at day 14.
The overall in-hospital mortality rate was 11.1% (ﬁve
of 45) as a result of three deaths, at days 33, 35, and 111,
caused by multiorgan failure (one patient with ischemic
colitis). The highest mortality rate was in patients treated
by HAR after a previous TEVAR (three of six patients
[50%]) and in zone 0 (four of six patients [67%]). After
Table VI. Risk factor analysis for perioperative death by Cox regression analysis
Risk factor
Univariate Multivariate
Unadjusted HR (95% CI) P Adjusted HR (95% CI) P
Zone 0 vs zone 1 and 2a 18.8 (3.4-104) .001 12.2 (1.0-147) .049
Emergent vs electivea 12.0 (2.2-65.8) .004 7.06 (1.0-51.1) .05
Re-TEVAR vs TEVARa 7.01 (1.4-34.9) .017 1.17 (0.12-11.9) .89
Female vs malea 5.96 (1.2-29.6) .029 .81 (0.09-7.4) .85
CM >200 vs 200a mL 6.01 (0.7-51.5) .102 1.82 (0.12-27.0) .67
One-staged vs two-stageda 2.38 (0.48-11.8) .29 . .
>60 vs 60a years 2.17 (0.39-11.9) .37 . .
CI, Conﬁdence interval; CM, contrast medium; HR, hazard ratio; TEVAR, thoracic endovascular aortic repair.
aReference category.
Fig 2. Freedom from reintervention is shown in 44 patients treated with supra-aortic debranching and thoracic
endovascular aortic repair (TEVAR). *Standard error >10% at 38.9 months.
JOURNAL OF VASCULAR SURGERY
1494 Bünger et al December 2013amedian follow-up of 20.8months (range, 0.3-70months),
the overall mortality was 13.3% (six of 45). One late death of
unknown cause occurred 6 months after uneventful zone 2
HAR for an acute ruptured type B dissection.
The Kaplan-Meier survival estimate at 1 year was 85%.
The difference in survival between zones 1 and 2 repair was
not statistically signiﬁcant (P ¼ .74), whereas the survival
difference between zone 0 and zones 1 and 2 repair was
highly statistically signiﬁcant (P < .001; Fig 1). Zone 0
HAR and emergent procedures were independent predic-
tors for death in the multivariate Cox regression analysis
(Table VI).
Morbidity. One of the 45 patients (2.2%) in the study
required a reoperation for major bleeding after zone 0
debranching. In two patients (4.4%), left recurrentlaryngeal nerve injury was diagnosed related to the
debranching procedure. Two patients experienced minor
wound complications (lymphatic swelling), without any
need for further treatment. In one patient (2%), transfe-
moral retrograde TEVAR was impossible due to a gothic
arch, necessitating sternotomy with antegrade stent graft
placement. Strokes occurred in four patients, major in
one and minor in three, resulting in a stroke rate of
8.8%. Paraplegia developed in one patient (2.2%), who
completely recovered after lumbar drainage. Cardiocircula-
tory complications were observed in three patients (6.7%)
and pulmonary complications in 10 (22.2%). Renal insufﬁ-
ciency developed in ﬁve patients (11%), with the need for
temporary dialysis in three patients and permanent dialysis
in two. One patient with ischemic colitis required partial
JOURNAL OF VASCULAR SURGERY
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one patient (2.2%) 14 days after complete debranching
and zone 0 TEVAR, with fatal outcome. No bypass
dysfunction was seen during follow-up.
The overall early and late endoleak rates (type IA, IB,
II) were 27% (12 of 44) and 43% (13 of 30), respectively,
with four patients (9%) developing false lumen enlarge-
ment (three patients with chronic expanding type B aortic
dissection). Reintervention was necessary in eight patients
(18%), with freedom of reintervention in 91% at 1 year
and 81% at 2 years (Fig 2). The major cause for reinterven-
tion was type IA endoleak, with false lumen enlargement of
the descending aorta in 7% (three of 44) and penetrating
aortic ulcer at the distal end of the thoracic stent graft
in 7% (three of 44). Reintervention procedures were
ascending supra-aortic debranching and zone 0 TEVAR
in one patient with previous zone 1 HAR, stent graft
extension at the distal end in three patients, LSA-
plugging in one, coiling of false lumen in two, and renal
stenting in one. The technical success rate for secondary
interventions wasw90%, resulting in complete false lumen
thrombosis at the level of descending aorta in 14 patients
(31%) after a median follow-up of 20 months. No conver-
sion to surgical aortic arch repair was needed.
DISCUSSION
HAR has been demonstrated as an effective alternative
to open surgery, with decreased morbidity and mortality in
selected patients.10 HAR may give equivalent or better
long-term outcomes for patients at high risk for surgical
repair.11 At present, few data are available on clinical
outcomes of HAR in patients with aortic dissection.
Reports on HAR usually combine patients with aortic
aneurysms, dissection, and other pathologies without
routine analysis of these different cohorts in a separate
manner. A recent review of hybrid procedures for aortic
arch dissection and other arch diseases found 27 studies
in which 629 of 826 patients (76%) were treated by
HAR in a proportion of 23% to 100%.4 A search for articles
that include HAR and dissection found only 12 studies in
which 92 patients were treated for aortic dissection. Owing
to the large heterogeneity of patients treated, it is difﬁcult
to compare or pool published results across studies.4
Our study is the ﬁrst report on HAR exclusively in
patients with type B aortic dissection. With a total of 45
patients undergoing debranching procedure and TEVAR
in 44 (98%), our results will help readers to understand
the value of HAR for complicated type B aortic dissection.
The technical success rate of almost 90% in type B aortic
dissection in our series and an in-hospital mortality of
11% compares favorably with a recent review in which
hybrid arch procedures in the dissected aorta showed
a mortality risk ranging from 0% to 14.3%, with a pooled
event ratio of 9.8%.4
There was an unsatisfactory outcome in our patients
after complete debranching and TEVAR, resulting in
a mortality rate of almost 70%, which is even higher than
results of other groups reporting mortality rates of 27%,1230%,13 and 44%.14 In a recent review, HAR in zone
0 was associated with a mortality rate that was three times
higher than repair involving zone 1.4
Since HAR became available at our center, all patients
with complicated type B dissection involving the aortic arch
have been treated with HAR. Considering such a high
mortality rate in our series, however, it may be prudent
to reconsider patients with chronic expanding type B
dissection for open semi-arch or total arch repair.
New endovascular techniques for treating difﬁcult aortic
arch lesions include stenting of the branch arteries (chimney
stents) and fenestrated and branched endografts, but
experiences in aortic arch repair are very limited.9,12,13,15-17
Fenestrated or branched stent grafts might be a future
solution for zone 0 endovascular repair in chronic type B
dissection. The utility in complicated aortic dissection (in
the light of long manufacturing times of fenestrated and
branched stent grafts), however, needs to be explored.
Nevertheless, supra-aortic debranching by itself is a safe
surgical procedure with a low complication rate.18 In our
study, no perioperative deaths occurred in high-risk
patients after supra-aortic debranching for type B aortic
dissection. Furthermore, the 6.6% rate of nonfatal compli-
cations for local reasons, including major bleeding needing
reoperation and left recurrent laryngeal nerve injury, was
low. Left recurrent laryngeal nerve injury developed in
two of 23 patients (8.7%) after LSA transposition, which
is similar to the nerve injury rate after LSA bypass grafting
(9.2%) and LSA transposition (11.2%) for occlusive
disease.19 Interestingly, the 22 patients in our study
without surgical exposure of the proximal subclavian artery
showed no symptoms of nerve injury (15 after LSA bypass,
two after axillary bypass, and ﬁve without revasculariza-
tion). Although LSA transposition is the preferred tech-
nique because of a low infection rate (avoidance of graft
in zone 2 debranching) and superior vessel patency,19 we
now recommend subclavian or axillary bypass instead of
LSA transposition in type B aortic dissection and difﬁcult
surgical exposure of the proximal LSA.
Stroke rate in our patients was 8.8%, which is higher
than reported.20 Stroke can occur as the result of clamping
or embolism formation during the debranching proce-
dure20 or as the result of wire manipulation during
TEVAR.11
Endoleaks after TEVAR are frequently observed,11
with early endoleak rates of 16%,21 27%,12 and 42%.14
Although early endoleaks were observed in 27% after
HAR in our series, about 18% were repaired after a median
follow-up of 2 years by means of coiling (in two patients)
or proximal cuff placement (one patient). Again, the reason
for endoleak formation appears to be mostly related to
inadequate length of the landing zone and the dynamics
of aortic pathology. A wider landing zone would most
likely have avoided some endoleak, however, at the expense
of more proximal (zone 0) debranching and thus incurring
a higher risk for more adverse vascular events.
Reintervention was needed in 18% after a median
follow-up of nearly 2 years to ﬁx initially occurring
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ventions was w90%, highlighting the need for a close
surveillance in all patients after TEVAR.
One potential limitation of our study is that patients
were not separated according to the time onset of symp-
toms (ie, patients with acute, subacute, or chronic dissec-
tions). A combined analysis of this study population,
however, is eligible to better understand the value of
HAR for aortic dissection, where data are rare up to now.
CONCLUSIONS
HAR repair in zones 1 and 2 appears a viable alterna-
tive to conventional aortic arch surgery in patients with
complicated type B aortic dissection. Stroke and endoleaks
remain complications that need to be addressed. Treatment
of type B aortic dissection with complete supra-aortic
debranching and TEVAR in zone 0, however, is associated
with high mortality. Improved technology with branched
stent grafts might be advantageous for interventions in
zone 0.AUTHOR CONTRIBUTIONS
Conception and design: CB, SK, CN
Analysis and interpretation: CB, SK, CN, AL, WS
Data collection: CB, ML, SK, HI
Writing the article: CB, AG
Critical revision of the article: CB, SK, WS, AL, HI, AG,
CN
Final approval of the article: CB, CN
Statistical analysis: AG, CB
Obtained funding: Not applicable
Overall responsibility: CBREFERENCES
1. Nienaber CA, Kische S, Ince H, Fattori R. Thoracic endovascular
aneurysm repair for complicated type B aortic dissection. J Vasc Surg
2011;54:1529-33.
2. Fattori R, Tsai TT, Myrmel T, Evangelista A, Cooper JV, Trimarchi S,
et al. Complicated acute type B dissection: is surgery still the best
option?: a report from the International Registry of Acute Aortic
Dissection. JACC Cardiovasc Interv 2008;1:395-402.
3. Tsai TT, Isselbacher EM, Trimarchi S, Bossone E, Pape L, Januzzi JL,
et al. Acute type B aortic dissection: does aortic arch involvement affect
management and outcomes? Insights from the International Registry of
Acute Aortic Dissection (IRAD). Circulation 2007;116(11 Suppl):
I150-6.
4. Cao P, De Rango P, Czerny M, Evangelista A, Fattori R, Nienaber C,
et al. Systematic review of clinical outcomes in hybrid procedures for
aortic arch dissections and other arch diseases. J Thorac Cardiovasc
Surg 2012;144:1286.e2-1300.e2.5. Antoniou GA, El Sakka K, Hamady M, Wolfe JH. Hybrid treatment of
complex aortic arch disease with supra-aortic debranching and endo-
vascular stent graft repair. Eur J Vasc Endovasc Surg 2010;39:683-90.
6. Mitchell RS, Ishimaru S, Ehrlich MP, Iwase T, Lauterjung L,
Shimono T, et al. First International Summit on Thoracic Aortic
Endografting: roundtable on thoracic aortic dissection as an indication
for endografting. J Endovasc Ther 2002;9(Suppl 2):II98-105.
7. Nienaber CA, Kische S, Rehders TC, Schneider H, Chatterjee T,
Bünger CM, et al. Rapid pacing for better placing: comparison of
techniques for precise deployment of endografts in the thoracic aorta.
J Endovasc Ther 2007;14:506-12.
8. Nienaber CA, Kische S, Zeller T, Rehders TC, Schneider H,
Lorenzen B, et al. Provisional extension to induce complete attachment
after stent-graft placement in type B aortic dissection: the PETTI-
COAT concept. J Endovasc Ther 2006;13:738-46.
9. Fillinger MF, Greenberg RK, McKinsey JF, Chaikof EL. Reporting
standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg
2010;52:1022-33.
10. Eagleton MJ, Greenberg RK. Hybrid procedures for the treatment of
aortic arch aneurysms. J Cardiovasc Surg (Torino) 2010;51:807-19.
11. Milewski RK, Szeto WY, Pochettino A, Moser GW, Moeller P,
Bavaria JE. Have hybrid procedures replaced open aortic arch recon-
struction in high-risk patients? A comparative study of elective open
arch debranching with endovascular stent graft placement and
conventional elective open total and distal aortic arch reconstruction.
J Thorac Cardiovasc Surg 2010;140:590-7.
12. Geisbusch P, Kotelis D, Eschner MM, Hyhlik-Durr A, Bockler D.
Complications after aortic arch hybrid repair. J Vasc Surg 2011;53:
935-41.
13. Vallejo N, Rodriguez-Lopez JA, Heidari P, Wheatley G, Caparrelli D,
Ramaiah V, et al. Hybrid repair of thoracic aortic lesions for zone 0 and
1 in high risk patients. J Vasc Surg 2011;55:318-25.
14. Antoniou GA, Mireskandari M, Bicknell CD, Cheshire NJ, Gibbs RG,
Hamady M, et al. Hybrid repair of the aortic arch in patients with
extensive aortic disease. Eur J Vasc Endovasc Surg 2010;40:715-21.
15. Chuter TA, Schneider DB, Reilly LM, Lobo EP, Messina LM.
Modular branched stent graft for endovascular repair of aortic arch
aneurysm and dissection. J Vasc Surg 2003;38:859-63.
16. Cires G, Noll RE Jr, Albuquerque FC Jr, Tonnessen BH,
Sternbergh WC 3rd. Endovascular debranching of the aortic arch
during thoracic endograft repair. J Vasc Surg 2011;53:1485-91.
17. Ma H, Yang HY, Zou JJ, Zhang XW. Management with the insufﬁ-
cient proximal landing zone for endovascular repair in aortic dissection.
Chin Med J (Engl) 2011;124:3003-7.
18. Byrne J, Darling RC, Roddy SP, Mehta M, Paty PS, Kreienberg PB,
et al. Long term outcome for extra-anatomic arch reconstruction. An
analysis of 143 procedures. Eur J Vasc Endovasc Surg 2007;34:444-50.
19. Cinà CS, Safar HA, Laganà A, Arena G, Clase CM. Subclavian carotid
transposition and bypass grafting: consecutive cohort study and
systematic review. J Vasc Surg 2002;35:422-9.
20. Gottardi R, Funovics M, Eggers N, Hirner A, Dorfmeister M,
Holfeld J, et al. Supra-aortic transposition for combined vascular and
endovascular repair of aortic arch pathology. Ann Thorac Surg
2008;86:1524-9.
21. Lotﬁ S, Clough RE, Ali T, Salter R, Young CP, Bell R, et al. Hybrid
repair of complex thoracic aortic arch pathology: long-term outcomes
of extra-anatomic bypass grafting of the supra-aortic trunk. Cardiovasc
Intervent Radiol 2013;36:46-55.
Submitted Jan 21, 2013; accepted May 14, 2013.
